Medtronic plc (MDT) FY2025 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-04-27 to 2024-07-26

Swipe to see the full flow
Medtronic plc cash flow reconciliation, Apr 27, 2024 through Jul 26, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $986,000,000.00Net income → Operating adjustments reconciliation: $63,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $662,000,000.00Accounts receivable, net → Operating adjustments reconciliation: $110,000,000.00Deferred income taxes → Operating adjustments reconciliation: $88,000,000.00Stock-based compensation → Operating adjustments reconciliation: $83,000,000.00Provision for credit losses → Operating adjustments reconciliation: $18,000,000.00Operating adjustments reconciliation → Accounts payable and accrued liabilities: $604,000,000.00Operating adjustments reconciliation → Inventories: $217,000,000.00Operating adjustments reconciliation → Other operating assets and liabilities: $194,000,000.00Operating adjustments reconciliation → Other, net: $9,000,000.00Sales and maturities of investments → investing reconciliation: $2,157,000,000.00investing reconciliation → Purchases of investments: $1,879,000,000.00investing reconciliation → Additions to property, plant, and equipment: $520,000,000.00investing reconciliation → Other investing activities, net: $17,000,000.00Net cash used in financing activities → financing reconciliation: $731,000,000.00Issuance of long-term debt → financing reconciliation: $3,209,000,000.00Issuance of ordinary shares → financing reconciliation: $89,000,000.00financing reconciliation → Repurchase of ordinary shares: $2,492,000,000.00financing reconciliation → Dividends to shareholders: $898,000,000.00financing reconciliation → Change in current debt obligations, net: $624,000,000.00financing reconciliation → Other financing activities: $15,000,000.00Net cash used in investing activities → investing reconciliation: $259,000,000.00Exchange-rate effect → Cash sources and uses: $31,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,284,000,000.00Net cash from operating activities → Cash sources and uses: $986,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $1,311,000,000.00Cash sources and uses → Net cash used in investing activities: $259,000,000.00Cash sources and uses → Net cash used in financing activities: $731,000,000.00Accounts receivable, net: $110,000,000.00Accounts & notes receivable+$110.00 MStock-based compensation: $83,000,000.00Stock-based compensation+$83.00 MDepreciation and amortization: $662,000,000.00Depreciation & amortization+$662.00 MNet income: $1,049,000,000.00Net income+$1.05 BProvision for credit losses: $18,000,000.00Credit loss provision+$18.00 MOther operating assets and liabilities: -$194,000,000.00Other working capital, net−$194.00 MDeferred income taxes: $88,000,000.00Deferred taxes & credits+$88.00 MInventories: -$217,000,000.00Inventories−$217.00 MOther, net: -$9,000,000.00Other non-cash items−$9.00 MAccounts payable and accrued liabilities: -$604,000,000.00Payables & accrued liabilities−$604.00 MNet cash from operating activities: $986,000,000.00Operating cash+$986.00 MOperating adjustments reconciliation: $1,024,000,000.00Change in current debt obligations, net: -$624,000,000.00Short-term debt ≤3 months, net−$624.00 MDividends to shareholders: -$898,000,000.00Common dividends paid−$898.00 MOther financing activities: -$15,000,000.00Other financing, net−$15.00 MIssuance of long-term debt: $3,209,000,000.00Long-term debt issued+$3.21 BRepurchase of ordinary shares: -$2,492,000,000.00Common stock repurchases−$2.49 BIssuance of ordinary shares: $89,000,000.00Equity issued+$89.00 MNet cash used in financing activities: -$731,000,000.00. Cash required to fund net payments.Financing cash−$731.00 Mfinancing reconciliation: $4,029,000,000.00Additions to property, plant, and equipment: -$520,000,000.00PP&E purchases−$520.00 MSales and maturities of investments: $2,157,000,000.00Investment sales & maturities+$2.16 BPurchases of investments: -$1,879,000,000.00Investment purchases−$1.88 BOther investing activities, net: -$17,000,000.00Other investing, net−$17.00 MNet cash used in investing activities: -$259,000,000.00. Cash required to fund net payments.Investing cash−$259.00 Minvesting reconciliation: $2,416,000,000.00Cash sources and uses: $2,301,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,284,000,000.00Beginning cash$1.28 BEnding cash: Cash, cash equivalents, and restricted cash: $1,311,000,000.00Ending cash$1.31 BExchange-rate effect: $31,000,000.00FX effect+$31.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$466.00 MOperating cash − cash spent on PP&ECash flow / Net income0.94×Operating cash flow ÷ net incomeNet cash change+$27.00 MEnding cash − beginning cash
Chart details

Medtronic plc cash flow reconciliation, Apr 27, 2024 through Jul 26, 2024

Cash flows for Apr 27, 2024 through Jul 26, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Apr 26, 2024. Ending cash: Jul 26, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Apr 26, 2024
1,284,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
986,000,000 US dollars. Net cash provided.
Accounts receivable, net
110,000,000 US dollars
Stock-based compensation
83,000,000 US dollars
Depreciation and amortization
662,000,000 US dollars
Net income
1,049,000,000 US dollars
Provision for credit losses
18,000,000 US dollars
Other operating assets and liabilities
negative 194,000,000 US dollars
Deferred income taxes
88,000,000 US dollars
Inventories
negative 217,000,000 US dollars
Other, net
negative 9,000,000 US dollars
Accounts payable and accrued liabilities
negative 604,000,000 US dollars
Investing activities
negative 259,000,000 US dollars. Net cash used.
Additions to property, plant, and equipment
negative 520,000,000 US dollars
Sales and maturities of investments
2,157,000,000 US dollars
Purchases of investments
negative 1,879,000,000 US dollars
Other investing activities, net
negative 17,000,000 US dollars
Financing activities
negative 731,000,000 US dollars. Net cash used.
Change in current debt obligations, net
negative 624,000,000 US dollars
Dividends to shareholders
negative 898,000,000 US dollars
Other financing activities
negative 15,000,000 US dollars
Issuance of long-term debt
3,209,000,000 US dollars
Repurchase of ordinary shares
negative 2,492,000,000 US dollars
Issuance of ordinary shares
89,000,000 US dollars
Operating adjustment reconciliation
1,024,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
4,029,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
2,416,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
31,000,000 US dollars
Ending cash on Jul 26, 2024
1,311,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
2,301,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
27,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.94×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
986,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
520,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
466,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $986.00M of net income directly to operating cash and $63.00M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 986,000,000 US dollars minus 520,000,000 US dollars equals 466,000,000 US dollars.
Medtronic plc (MDT) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!